| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Ensysce Biosciences, Inc. | Chief Commercial Officer | Stock Option | 50,000 | 17 Feb 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ENSC | Ensysce Biosciences, Inc. | 17 Feb 2022 | 1 | $0 | 4 | Chief Commercial Officer | 24 Feb 2022, 18:03 |
| ENSC | Ensysce Biosciences, Inc. | 30 Jun 2021 | 2 | $0 | 4 | Chief Commercial Officer | 02 Jul 2021, 18:07 |
| ENSC | Ensysce Biosciences, Inc. | 30 Jun 2021 | 0 | $0 | 3 | Chief Commercial Officer | 02 Jul 2021, 15:35 |